US open: Stocks point higher as Omicron fears ease, inflation rises

US futures

Dow futures +0.34% at 35870

S&P futures +0.35% at 4710

Nasdaq futures +0.25% at 16291

In Europe

FTSE +0.45% at 7352

Dax +0.8% at 15692

Euro Stoxx +0.7% at 4247

Learn more about trading indices

Omicron fear ease

US stocks are heading for a positive start as Omicron fears continue to recede and optimism surrounding the economic outlook builds.

All major US indices are set to end the week higher as an increasing number of studies show that fewer patients need hospital treatment with Omicron compared to Delta. This raises expectations that the Omicron variant won’t derail the global economic recovery.

Adding to the upbeat news, AstraZeneca confirmed that three doses of its COVID vaccine provides protection against Omicron, meanwhile Novavax has said that two shots of its COVID vaccine triggered an immune response to Omicron.

Data wise, investors had plenty to digest. US PCE index, the Fed’s preferred measure for inflation rose to 5.7% in November, up from 5% in October and ahead of the 5.7% forecast.

Initial jobless claims fell last week to 205k, down from 206k the previous week and in line with forecasts.

Furthermore US durable goods orders rose 0.8% MoM ahead of the 0.6% rise expected and up from 0.3% in October.

With inflation elevated and the labour market improving the data supports the more hawkish Fed that we saw in the latest Fed meeting.

The Fed in its December meeting accelerated the pace at which it tapers bond purchases and pointed to three interest rate rises in 2022.

Where next for the S&P50?

The S&P500 is extending its rebound from the 100 sma reached hit on Monday. The move above the 50 sma plus the bullish RSI are keeping buyer’s hopeful of further upside. The price needs to overcome the resistance zone at 4713/20 in order to look towards 4750 and fresh all-time highs. Failure to push above this level could see the price head back towards the 50 sma at 4634, with a move below here negating the near-term uptrend. A move below 4530 the 100 sma could see sellers gain traction.

FX – USD rises, GBP retakes 1.34

The USD has traded under pressure across the week as the risk on mood has prompted investors to buy into riskier currencies. However, the greenback is rising after the US data drop supports a more hawkish Fed.

GBP/USD is trading at a monthly high on easing concerns of tighter COVID restrictions. A recent study conducted in England and Scotland showed that the Omicron variant is sending few people to hospital. Furthermore, the government agreed to hold off from announcing tighter restrictions.

GBP/USD +0.55% at 1.3425

EUR/USD -0.18% at 1.1306

Oil rises 7% in 3 days

Oil prices are moving higher for a third straight session on encouraging COVID news. Oil prices have jumped almost 7% in three days as the markets become more confident that Omicron won’t derail the economic recovery.

Upbeat news on vaccines and drug treatments for COVID is offsetting news that the Chinese city of Xian has imposed lockdown restrictions on its 13 million inhabitants.

Larger than expected drawdowns in oil inventories have also supported oil prices this week. According to the latest EIA report inventories declined by a larger than expected 4.7 million barrels.

Looking ahead the Baker Hughes rig count could provide further impetus for oil traders.

WTI crude trades +0.1% at $72.78

Brent trades +0.1% at $75.41

Looking ahead

15:00 US Michigan consumer sentiment

15:00 US New home sales

18:00 Baker Hughes rig count

How to trade with City Index

Follow these easy steps to start trading with City Index today:

Open a City Index account, or log-in if you’re already a customer.
Search for the market you want to trade in our award-winning platform.
Choose your position and size, and your stop and limit levels
Place the trade.

This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

StoneX Financial Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit www.cityindex.com/en-sg/terms-and-policies for the complete Risk Disclosure Statement.

ALL TRADING INVOLVES RISKS. LOSSES CAN EXCEED DEPOSITS.

City Index is a trading name of StoneX Financial Pte. Ltd. (“SFP”) for the offering of dealing services in Contracts for Differences (“CFD”). SFP holds a Capital Markets Services Licence issued by the Monetary Authority of Singapore for Dealing in Exchange-Traded Derivatives Contracts, Over-the-Counter Derivatives Contracts, and Spot Foreign Exchange Contracts for the Purposes of Leveraged Foreign Exchange Trading. SFP is also both Derivatives Trading and Clearing member of the Singapore Exchange (“SGX”). SFP is a wholly-owned subsidiary of StoneX Group Inc.

The information provided herein is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to invest, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk.

The information does not represent an offer of, or solicitation for, a transaction in any investment product. Any views and opinions expressed may be changed without an update. To understand the risks and costs involved, please visit the section captioned “Important Information” and the “Risk Disclosure Statement”.

The information herein is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation.

StoneX Financial Pte. Ltd. 1 Raffles Place, #18-61, One Raffles Place Tower 2, Singapore 048616. Tel: 6309 1000. Co. Reg. No.: 201130598R.

This advertisement has not been reviewed by the Monetary Authority of Singapore.